The DOI matches its Crossref record, with a small difference in title or year; 24 of the 25 references it cites were found in a registry or an index.
Effects of Oral Contraceptives Containing Ethinylestradiol with Either Drospirenone or Levonorgestrel on Various Parameters Associated with Well-Being in Healthy Women: A Randomized, Single-Blind, Parallel-Group, Multicentre Study
Abstract
Background The combined oral contraceptive Yasmin (drospirenone 3 mg plus ethinylestradiol 30 microg [DRSP 3 mg/EE 30 microg]) has been shown to be a well tolerated and effective combination that provides high contraceptive reliability and good cycle control. Furthermore, DRSP 3 mg/EE 30 microg has been shown to have a positive effect on premenstrual symptoms and well-being/health-related quality of life, and to improve the skin condition of women with acne. To date, however, there have been relatively few studies that have compared the effects of DRSP 3 mg/EE 30 microg on the general well-being of women with those of other oral contraceptives. Objectives To compare the impact of DRSP 3 mg/EE 30 microg with that of levonorgestrel 150 microg/EE 30 microg (LNG 150 microg/EE 30 microg; Microgynon 30) on various parameters associated with well-being in healthy female subjects. Methods This was a randomized, single-blind, parallel-group, multicentre study conducted using 21/7-day regimens of DRSP 3 mg/EE 30 microg and LNG 150 microg/EE 30 microg over seven cycles. Efficacy parameters included: changes in Menstrual Distress Questionnaire (MDQ) normative T scores; the proportion of subjects with acne; and menstrual symptoms. Cycle control and subjective well-being parameters were also assessed. Results Treatment with DRSP 3 mg/EE 30 microg had similar beneficial effects on symptoms of water retention and impaired concentration to LNG 150 microg/EE 30 microg, but was significantly be…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Current data show no consistent difference in acne responses based on COC formulations or dosages and do not support the superiority of one COC over another for acne treatment”
From Guidelines of care for the management of acne vulgaris (2024) · cites this paper as [199]
Citations
Cites
The Development of a Menstrual Distress Questionnaire
MOOS, R. H. (1968) · Psychosomatic Medicine · doi:10.1097/00006842-196811000-00006 · Cited by 880
Drospirenone: pharmacology and pharmacokinetics of a unique progestogen
Krattenmacher, R. (2000) · Contraception · doi:10.1016/s0010-7824(00)00133-5 · Cited by 376
Hormone withdrawal symptoms in oral contraceptive users
Sulak, P. (2000) · Obstetrics & Gynecology · doi:10.1016/s0029-7844(99)00524-4 · Cited by 274
Drospirenone: a Novel Progestogen with Antimineralocorticoid and Antiandrogenic Activity
MUHN, P., FUHRMANN, U., FRITZEMEIER, K. H., KRATTENMACHER, R., & SCHILLINGER, E. (1995) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1995.tb31386.x · Cited by 185
van Vloten, W. A., van Haselen, C. W., van Zuuren, E. J., Gerlinger, C., & Heithecker, R. (2002) · PubMed · Cited by 173
Self-citationEvaluation of a Unique Oral Contraceptive in the Treatment of Premenstrual Dysphoric Disorder
Freeman, E. W., Kroll, R., Rapkin, A., Pearlstein, T., Brown, C., Parsey, K., Zhang, P., Patel, H., & Foegh, M. (2001) · Journal of Women's Health & Gender-Based Medicine · doi:10.1089/15246090152543148 · Cited by 163
Sulak, P. J., Kuehl, T. J., Ortiz, M., & Shull, B. L. (2002) · American Journal of Obstetrics and Gynecology · doi:10.1067/mob.2002.122988 · Cited by 154
Parsey, K., & Pong, A. (2000) · Contraception · doi:10.1016/s0010-7824(00)00083-4 · Cited by 149
Huber, J., Foidart, J., Wuttke, W., Merki‐Feld, G. S., The, H. S., Gerlinger, C., Schellschrmdt, I., & Heithecker, R. (2000) · The European Journal of Contraception & Reproductive Health Care · doi:10.1080/13625180008500375 · Cited by 147
Self-citationThe androgenicity of progestins
Darney, P. D. (1995) · The American Journal of Medicine · doi:10.1016/s0002-9343(99)80067-9 · Cited by 138
Research works printed but not linked: 6
- Borenstein, 2003 Feb, J Reprod Med, 48, 79
- Brown, 2002 Jan, J Reprod Med, 47, 14
- Thorneycroft, 2004 Aug, Cutis, 74, 123
- van Vloten, 2002 Apr, Cutis, 69, 2
- Sulak, 2000 Feb, Obstet Gynecol, 95, 261
- Oranratanaphan, 2006 Oct, J Med Assoc Thai, 89, S17
Cited by
Guidelines of care for the management of acne vulgaris
Reynolds, R. V., Yeung, H., Cheng, C. E., Cook-Bolden, F., Desai, S. R., Druby, K. M., Freeman, E. E., Keri, J. E., Stein Gold, L. F., Tan, J. K. L., et al. (2024) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2023.12.017 · Cited by 518
Combined oral contraceptive pills for treatment of acne
Arowojolu, A. O., Gallo, M. F., Lopez, L. M., & Grimes, D. A. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004425.pub6 · Cited by 308
Oral contraceptives containing drospirenone for premenstrual syndrome
Lopez, L. M., Kaptein, A. A., & Helmerhorst, F. M. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006586.pub4 · Cited by 270
The Effects of Hormonal Contraceptives on Female Sexuality: A Review
Burrows, L. J., Basha, M., & Goldstein, A. T. (2012) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2012.02848.x · Cited by 247
Sundström-Poromaa, I., Comasco, E., Sumner, R., & Luders, E. (2020) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2020.100856 · Cited by 191
Metadata
- Authors
- Kelly, S., Davies, E., Fearns, S., McKinnon, C., Carter, R., Gerlinger, C., & Smithers, A.
- Affiliations
- NHS Greater Glasgow and Clyde (GB)
- Park-Klinik Birkenwerder (DE)
- Corresponding author
- Carter, Rick
- ORCID
- Gerlinger, Christoph
- Venue
- Clinical Drug Investigation
- Published
- 2010-05
- Volume
- 30
- Issue
- 5
- Pages
- 325-336
- ISSN
- 0114-2402 (ISSN-L)
- 1173-2563
- OpenAlex
- W180781522
- Cited by
- 73
- References
- 25
- Citations by year
- 2026: 3 · 2025: 4 · 2024: 11 · 2023: 5 · 2022: 3 · 2021: 9 · 2020: 4 · 2019: 2 · 2018: 4 · 2017: 6 · 2016: 3 · 2015: 2 · 2014: 4 · 2013: 3 · 2012: 7
- FWCI
- 4.12
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Drug Investigation (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Reproductive Health and Contraception
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Menstrual Health and Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Menopause: Health Impacts and Treatments
- Keywords
- drospirenone, levonorgestrel, ethinyl estradiol, Yasmin, combined oral contraceptives, well-being, menstrual symptoms, menstrual distress, acne, water retention, negative affect, cycle control, health-related quality of life, healthy women, menstrual cycle phases
- MeSH terms
- Adolescent, Adult, Androstenes, Body Water, Contraceptives, Oral, Combined, Drug Combinations, Ethinyl Estradiol, Female, Humans, Menstrual Cycle, Quality of Life, Single-Blind Method, Levonorgestrel, Statistics, Nonparametric, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Effects of Oral Contraceptives Containing Ethinylestradiol with Either Drospirenone or Levonorgestrel on Various Parameters Associated with Well-Being in Healthy Women: A Randomized, Single-Blind, Parallel-Group, Multicentre Study. https://app.cochat.ai/papers/10.2165/11535450-000000000-00000
- The paper
- Kelly, S., Davies, E., Fearns, S., McKinnon, C., Carter, R., Gerlinger, C., & Smithers, A. (2010). Effects of Oral Contraceptives Containing Ethinylestradiol with Either Drospirenone or Levonorgestrel on Various Parameters Associated with Well-Being in Healthy Women: A Randomized, Single-Blind, Parallel-Group, Multicentre Study. Clinical Drug Investigation. https://doi.org/10.2165/11535450-000000000-00000
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.